Staphylococcus Aureus Bacteremia clinical trials

Explore recruiting staphylococcus aureus bacteremia clinical trials.

Recruiting staphylococcus aureus bacteremia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Staphylococcus Aureus Bacteremia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

Netherlands, Germany, Sweden, France

Therapeutic use (Phase IV) EU CTIS Study details

SAFE study

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

PK/PD of Cefadroxil in Staphylococcus Aureus Bacteremia, a preliminary study

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Treatment of penicillin susceptible Staphylococcus aureus bacteraemia with bensylpenicillin versus cloxacillin – a randomized controlled trial

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Staphylococcus Aureus Bacteremia trials by city

Staphylococcus Aureus Bacteremia clinical trials

Recruiting staphylococcus aureus bacteremia studies right now

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Linezolid Plus Standard of Care

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus

Staphylococcus Aureus Network Adaptive Platform Trial

Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Also recruiting in Europe

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

SAFE study

PK/PD of Cefadroxil in Staphylococcus Aureus Bacteremia, a preliminary study

Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study

Treatment of penicillin susceptible Staphylococcus aureus bacteraemia with bensylpenicillin versus cloxacillin – a randomized controlled trial

Staphylococcus Aureus Bacteremia trials by city

Other conditions